Autolus Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUTL and other ETFs, options, and stocks.

About AUTL

Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. 

CEO
Christian Martin Itin
CEOChristian Martin Itin
Employees
327
Employees327
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2018
Founded2018
Employees
327
Employees327

AUTL Key Statistics

Market cap
281.82M
Market cap281.82M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
157.84K
Average volume157.84K
High today
$3.17
High today$3.17
Low today
$2.75
Low today$2.75
Open price
$2.88
Open price$2.88
Volume
310.34K
Volume310.34K
52 Week high
$7.90
52 Week high$7.90
52 Week low
$1.96
52 Week low$1.96

AUTL News

Benzinga 2d
Autolus Therapeutics Stock Jumps After Bristol Myers Pact For Safety Switch System

In this article: Autolus Therapeutics plc (NASDAQ: AUTL) has entered into an agreement with Bristol-Myers Squibb Co (NYSE: BMY). The agreement grants Bristol...

Autolus Therapeutics Stock Jumps After Bristol Myers Pact For Safety Switch System

Analyst ratings

80%

of 10 ratings
Buy
80%
Hold
20%
Sell
0%

AUTL Earnings

-$0.60
-$0.40
-$0.20
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 2, Pre-Market
ActualExpected Nov 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.